Novocure
NVCR
#5712
Rank
S$1.70 B
Marketcap
Country
S$14.56
Share price
-4.48%
Change (1 day)
-0.57%
Change (1 year)
Categories

Earnings for Novocure (NVCR)

Earnings in 2026 (TTM): -S$0.12 Billion

According to Novocure 's latest financial reports the company's current earnings are S$0.72 Billion. In 2025 the company made an earning of -S$0.16 Billion, an increase over its 2024 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novocure from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.12 Billion-24.72%
2025 -S$0.16 Billion-1.33%
2024 -S$0.16 Billion-35.88%
2023 -S$0.25 Billion139.99%
2022 -S$0.11 Billion61.43%
2021 -S$62.66 Million-235.99%
2020 S$46.06 M630.75%
2019 S$6.3 M-115.08%
2018 -S$41.81 Million-15.13%
2017 -S$49.26 Million-66.9%
2016 -S$0.15 Billion10.26%
2015 -S$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-S$3.21 Million-97.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-S$94.12 Million-18.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-S$0.29 Billion 148.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-S$0.12 Billion 0.00% Jersey